fluoxetine has been researched along with Movement Disorders in 9 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (11.11) | 18.7374 |
1990's | 2 (22.22) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 4 (44.44) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aragones, JM | 1 |
Blanch, CE | 1 |
Guillen-Font, A | 1 |
Escote-Llobet, S | 1 |
Rozzini, L | 1 |
Chilovi, BV | 1 |
Conti, M | 1 |
Bertoletti, E | 1 |
Zanetti, M | 1 |
Trabucchi, M | 1 |
Padovani, A | 1 |
Morelli, E | 1 |
Moore, H | 1 |
Rebello, TJ | 1 |
Gray, N | 1 |
Steele, K | 1 |
Esposito, E | 1 |
Gingrich, JA | 1 |
Ansorge, MS | 1 |
Creed, MC | 1 |
Hamani, C | 1 |
Bridgman, A | 1 |
Fletcher, PJ | 1 |
Nobrega, JN | 1 |
Chen, JJ | 1 |
Swope, DM | 1 |
Takahashi, T | 1 |
Kobayashi, T | 1 |
Ozaki, M | 1 |
Takamatsu, Y | 1 |
Ogai, Y | 1 |
Ohta, M | 1 |
Yamamoto, H | 1 |
Ikeda, K | 1 |
Connor, DF | 1 |
Benjamin, S | 1 |
Ozbayrak, KR | 1 |
Lauterbach, EC | 1 |
Shillcutt, SD | 1 |
Steiner, W | 1 |
Fontaine, R | 1 |
9 other studies available for fluoxetine and Movement Disorders
Article | Year |
---|---|
[Buccolingual dyskinesia with justified hallucinations].
Topics: Alcoholism; Benzodiazepines; Clonazepam; Depressive Disorder; Dibenzothiazepines; Disulfiram; Female | 2014 |
Efficacy of SSRIs on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors.
Topics: Aged; Alzheimer Disease; Cholinesterase Inhibitors; Citalopram; Cognition; Cognition Disorders; Depr | 2010 |
Chronic 5-HT transporter blockade reduces DA signaling to elicit basal ganglia dysfunction.
Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Animals; Animals, Newborn; Basal Ganglia; Cell Count; C | 2011 |
Contribution of decreased serotonin release to the antidyskinetic effects of deep brain stimulation in a rodent model of tardive dyskinesia: comparison of the subthalamic and entopeduncular nuclei.
Topics: 5,7-Dihydroxytryptamine; Amphetamines; Analysis of Variance; Animals; Antipsychotic Agents; Autoradi | 2012 |
A case of complex movement disorder induced by fluoxetine with management of dystonia by botulinum toxin type A.
Topics: Aged; Anti-Dyskinesia Agents; Botulinum Toxins, Type A; Dyskinesia, Drug-Induced; Dystonic Disorders | 2005 |
G protein-activated inwardly rectifying K+ channel inhibition and rescue of weaver mouse motor functions by antidepressants.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tri | 2006 |
Case study: neuroleptic withdrawal dyskinesia exacerbated by ongoing stimulant treatment.
Topics: Antipsychotic Agents; Dextroamphetamine; Diphenhydramine; Fluoxetine; Humans; Male; Mental Disorders | 1995 |
Dyskinesia with fluoxetine: tardive or late-onset persistent, acute norfluoxetine dyskinesia?
Topics: Acute Disease; Animals; Diagnosis, Differential; Dyskinesia, Drug-Induced; Fluoxetine; Humans; Movem | 1997 |
Toxic reaction following the combined administration of fluoxetine and L-tryptophan: five case reports.
Topics: Adult; Akathisia, Drug-Induced; Arrhythmias, Cardiac; Drug Interactions; Female; Fluoxetine; Humans; | 1986 |